568
Views
4
CrossRef citations to date
0
Altmetric
For Debate

Does rosuvastatin increase serum levels of 25-hydroxy-vitamin D?

&
Pages 2-7 | Received 05 Oct 2011, Accepted 03 Nov 2011, Published online: 01 Jan 2012

References

  • Glossmann H H. Vitamin D - an update. Osteologie Forum 2010; (16):23–35.
  • Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM, Kastelein JJP, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359:2195 - 207; http://dx.doi.org/10.1056/NEJMoa0807646; PMID: 18997196
  • Zittermann A, Gummert JF, Börgermann J. The role of vitamin d in dyslipidemia and cardiovascular disease. Curr Pharm Des 2011; 17:933 - 42; http://dx.doi.org/10.2174/138161211795428786; PMID: 21418036
  • Goldstein MR, Mascitelli L, Pezzetta F. Rosuvastatin and vitamin D: might there be hypovitaminosis D on JUPITER?. Int J Cardiol 2010; 145:556 - 7; http://dx.doi.org/10.1016/j.ijcard.2010.05.022; PMID: 20557956
  • Gupta A, Thompson PD. The relationship of vitamin D deficiency to statin myopathy. Atherosclerosis 2011; 215:23 - 9; http://dx.doi.org/10.1016/j.atherosclerosis.2010.11.039; PMID: 21185021
  • Ware WR. The JUPITER lipid lowering trial and vitamin D: Is there a connection?. Dermatoendocrinol 2010; 2:50 - 4; http://dx.doi.org/10.4161/derm.2.2.13235; PMID: 21547097
  • Yavuz B, Ertugrul DT, Cil H, Ata N, Akin KO, Yalcin AA, et al. Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?. Cardiovasc Drugs Ther 2009; 23:295 - 9; http://dx.doi.org/10.1007/s10557-009-6181-8; PMID: 19543962
  • Ertugrul DT, Yavuz B, Cil H, Ata N, Akin KO, Kucukazman M, et al. STATIN-D Study: Comparison of the Influences of Rosuvastatin and Fluvastatin Treatment on the Levels of 25 Hydroxyvitamin D. Cardiovasc Ther 2010; In press PMID: 20370794
  • Gröbner J, Albold A, Blumthaler M, Cabot T, de La Casiniere A, Lenoble J, et al. Variability of spectral solar ultraviolet irradiance in an Alpine environment. J Geophys Res 2000; 105:D22 26991 - 7003; http://dx.doi.org/10.1029/2000JD900395
  • Lips P. Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 2007; 103:620 - 5; http://dx.doi.org/10.1016/j.jsbmb.2006.12.076; PMID: 17287117
  • Martin PD, Warwick MJ, Dane AL, Hill SJ, Giles PB, Phillips PJ, et al. Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers. Clin Ther 2003; 25:2822 - 35; http://dx.doi.org/10.1016/S0149-2918(03)80336-3; PMID: 14693307
  • Sakaeda T, Fujino H, Komoto C, Kakumoto M, Jin J, Iwaki K, et al. Effects of acid and lactone forms of eight HMG-CoA reductase inhibitors on CYP-mediated metabolism and MDR1-mediated transport. Pharm Res 2006; 23:506 - 12; http://dx.doi.org/10.1007/s11095-005-9371-5; PMID: 16388406
  • Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003; 77:204 - 10; PMID: 12499343
  • van Groningen L, Opdenoordt S, van Sorge A, Telting D, Giesen A, de Boer H. Cholecalciferol loading dose guideline for vitamin D-deficient adults. Eur J Endocrinol 2010; 162:805 - 11; http://dx.doi.org/10.1530/EJE-09-0932; PMID: 20139241
  • Binkley N, Gemar D, Engelke J, Gangnon R, Ramamurthy R, Krueger D, et al. Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. J Clin Endocrinol Metab 2011; 96:981 - 8; http://dx.doi.org/10.1210/jc.2010-0015; PMID: 21289249
  • Osmancevic A, Nilsen LT, Landin-Wilhelmsen K, Søyland E, Abusdal Torjesen P, Hagve TA, et al. Effect of climate therapy at Gran Canaria on vitamin D production, blood glucose and lipids in patients with psoriasis. J Eur Acad Dermatol Venereol 2009; 23:1133 - 40; http://dx.doi.org/10.1111/j.1468-3083.2009.03245.x; PMID: 19453805
  • Armas LAG, Dowell S, Akhter M, Duthuluru S, Huerter C, Hollis BW, et al. Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: the effect of UVB dose and skin color. J Am Acad Dermatol 2007; 57:588 - 93; http://dx.doi.org/10.1016/j.jaad.2007.03.004; PMID: 17637484
  • Fioletov VE, McArthur LJB, Mathews TW, Marrett L. Estimated ultraviolet exposure levels for a sufficient vitamin D status in North America. J Photochem Photobiol B 2010; 100:57 - 66; http://dx.doi.org/10.1016/j.jphotobiol.2010.05.002; PMID: 20554218
  • Heaney RP, Horst RL, Cullen DM, Armas LAG. Vitamin D3 distribution and status in the body. J Am Coll Nutr 2009; 28:252 - 6; PMID: 20150598
  • Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J. Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 1993; 91:2552 - 5; http://dx.doi.org/10.1172/JCI116492; PMID: 8390483
  • Reboul E, Goncalves A, Comera C, Bott R, Nowicki M, Landrier J, et al. Vitamin D intestinal absorption is not a simple passive diffusion: evidences for involvement of cholesterol transporters. Mol Nutr Food Res 2011; 55:691 - 702; http://dx.doi.org/10.1002/mnfr.201000553; PMID: 21280209
  • Matthan NR, Resteghini N, Robertson M, Ford I, Shepherd J, Packard C, et al. Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial. J Lipid Res 2010; 51:202 - 9; http://dx.doi.org/10.1194/jlr.M900032-JLR200; PMID: 19578163
  • Tremblay AJ, Lamarche B, Lemelin V, Hoos L, Benjannet S, Seidah NG, et al. Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men. J Lipid Res 2011; 52:558 - 65; http://dx.doi.org/10.1194/jlr.M011080; PMID: 21123766
  • Huebbe P, Nebel A, Siegert S, Moehring J, Boesch-Saadatmandi C, Most E, et al. APOE {varepsilon}4 is associated with higher vitamin D levels in targeted replacement mice and humans. FASEB J 2011; 25:3262 - 70; http://dx.doi.org/10.1096/fj.11-180935; PMID: 21659554
  • Gray RW, Weber HP, Dominguez JH, Lemann J. The metabolism of vitamin D3 and 25-hydroxyvitamin D3 in normal and anephric humans. J Clin Endocrinol Metab 1974; 39:1045 - 56; http://dx.doi.org/10.1210/jcem-39-6-1045; PMID: 4372244
  • Launay-Vacher V, Izzedine H, Deray G. Statins' dosage in patients with renal failure and cyclosporine drug-drug interactions in transplant recipient patients. Int J Cardiol 2005; 101:9 - 17; http://dx.doi.org/10.1016/j.ijcard.2004.04.005; PMID: 15860377
  • Schuster I, Egger H, Bikle D, Herzig G, Reddy GS, Stuetz A, et al. Selective inhibition of vitamin D hydroxylases in human keratinocytes. Steroids 2001; 66:409 - 22; http://dx.doi.org/10.1016/S0039-128X(00)00159-8; PMID: 11179750
  • Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, et al. Mutations in CYP24A1 and Idiopathic Infantile Hypercalcemia. N Engl J Med 2011; 365:410 - 21; http://dx.doi.org/10.1056/NEJMoa1103864; PMID: 21675912
  • Holmes EW, Garbincius J, McKenna KM. Non-linear analytical recovery in the DiaSorin Liaison immunoassay for 25-hydroxy vitamin D. Clin Chim Acta 2011; 412:2355 - 6; http://dx.doi.org/10.1016/j.cca.2011.09.003; PMID: 21925154
  • Grimnes G, Almaas B, Eggen AE, Emaus N, Figenschau Y, Hopstock LA, et al. Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed. Eur J Endocrinol 2010; 163:339 - 48; http://dx.doi.org/10.1530/EJE-09-1041; PMID: 20479012
  • Kleinert S, Horton R. Retraction–autologous myoblasts and fibroblasts versus collagen [corrected] for treatment of stress urinary incontinence in women: a [corrected] randomised controlled trial. Lancet 2008; 372:789 - 90; http://dx.doi.org/10.1016/S0140-6736(08)61320-3; PMID: 18774408
  • Demir CC, Mousa U, Anil C, Bozkus Y. Effects of atorvastatin and rosuvastatin therapy on serum 25-hydroxyvitamin D levels: a comparative study [European Congress of Endocrinology 2011, Rotterdam, April 30–May 4 - European Society of Endocrinology]. Endocrine Abstracts; 2011. (vol 26).